Share this Post

OvaScience (NASDAQ: OVAS) is a fertility company focused on the discovery, development and commercialization of novel treatments for infertility.

OvaScience is working to improve the treatment of female infertility based on patented technology exclusively licensed from Massachusetts General Hospital. The company’s team of scientists, physicians and advisers are recognized leaders in the field of reproductive medicine.